Thymic peptide

Thymosin Alpha-1

Thymosin Alpha-1 is investigated in immune-cell signaling. The cited study examines dendritic-cell maturation and antifungal responses in experimental systems.

Quantity per vial

Select variantCompare prices and choose a variant to set the quantity and add it to your quote.

Subtotal excludes freight and taxes. Availability and final terms are confirmed in the quote. Commercial and shipping terms

Mechanism and findings

Mixed · Study formulation · Dendritic cells and transplanted mice

Innate immune signaling

The peptide modified dendritic-cell responses and antifungal immunity in experimental systems involving Toll-like receptor signaling.

Romani et al., 2004 →

Literature findings; refer to the model and formulation studied.

Mechanism of action

Thymosin Alpha-1 — thymic peptide. The literature identity must be matched to the documented chemical form and composition of the supplied material.

The work linked dendritic-cell responses to MyD88-dependent and Toll-like receptor pathways involving p38 and NF-κB. Cell maturation and IL-12 production were connected to antifungal-immunity experiments in transplanted mice, not a universal measure of human immunity.

  • Toll-like receptor signaling

Romani et al., 2004

Studied findings 1
Mixed · Study formulation

Innate immune signaling

Dendritic cells and transplanted mice

The peptide modified dendritic-cell responses and antifungal immunity in experimental systems involving Toll-like receptor signaling.

View context
Study design
Original-study abstract; experimental design described in linked source
Sample scope / arm
Not extracted; consult original study
Comparator
See original-study context
Experimental context (not instructions for use)
Abstract-level extraction; full methods and tables still require review.
Source section / table / abstract
Abstract

Evidence concerns the studied material and model, not the supplied BLOPEP batch.

Romani et al., 2004

Sources and studies 1
  1. Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling.

    Romani L, Bistoni F, Gaziano R, Bozza S, Montagnoli C, Perruccio K, Pitzurra L, Bellocchio S, Velardi A, Rasi G, Di Francesco P, Garaci E · 2004 · Blood

    DOI: 10.1182/blood-2003-11-4036

Specifications and packaging

Nominal variant content; analytical results belong to the documented batch.

Material type
Peptide

Quality and analyses

Review specifications, analytical results and documentation for published batches.

Purity
>99%
Type
Declared specification

Published batches

Batch results have not yet been published on this page.

Storage

Consult the specific conditions in the supplied material documentation.

Delivery and commercial terms

Freight, timing and import terms will be confirmed in the quote for the selected destination.